Boothbay Fund Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,766
Closed -$255K 1489
2024
Q3
$255K Sell
6,766
-21,549
-76% -$831K 0.01% 1318
2024
Q2
$1.12M Sell
28,315
-4,157
-13% -$135K 0.03% 677
2024
Q1
$1.09M Buy
+32,472
New +$1.09M 0.02% 731

Other funds holding ATEX

Boothbay Fund Management's ATEX Position: Q4 2024 in Review

Boothbay Fund Management sold out of Anterix (ATEX) in Q4 2024, closing a stake of 6,766 shares — an estimated $255K sold.

Boothbay Fund Management first reported a position in ATEX in Q1 2024 and held it in 3 quarters. The position peaked at $1.12M in Q2 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

  • Boothbay Fund Management reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 6,766 Anterix shares in Q4 2024, an estimated $255K.
  • Boothbay Fund Management first reported a position in Anterix in Q1 2024 and held it in 3 quarters.
  • Boothbay Fund Management's Anterix position peaked at $1.12M in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.